市場調查報告書
商品編碼
939451

正電子發射斷層攝影(PET)的全球市場

Positron Emission Tomography (PET)

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球正電子發射斷層攝影(PET)市場雖然受到新型冠狀病毒感染疾病(COVID-19)大流行疫情及景氣衰退影響,但是從2019年到2025年預計仍將以1.1%的年複合成長率持續成長。

本報告提供全球正電子發射斷層攝影(PET)市場調查,提供市場概要,主要企業趨勢,市場趨勢與成長促進因素,各國市場分析,競爭情形等資訊。

目錄

I. 簡介,調查方法,調查範圍

II.摘要整理

第1章 市場概要

  • 各競爭公司的市場佔有率
  • 2019年和2025年的市場佔有率方案
  • Covid-19的影響和即將到來的全球景氣衰退

第2章 主要企業趨勢

第3章 市場趨勢與成長促進因素

第4章 全球市場的展望

III.市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介
目錄
Product Code: MCP14132

Abstract:

Global Positron Emission Tomography (PET) Market to Reach $793.6 Million by 2027

Amid the COVID-19 crisis, the global market for Positron Emission Tomography (PET) estimated at US$734.2 Million in the year 2020, is projected to reach a revised size of US$793.6 Million by 2027, growing at a CAGR of 1.1% over the analysis period 2020-2027. PET-CT, one of the segments analyzed in the report, is projected to record a 1% CAGR and reach US$727.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PET-MR segment is readjusted to a revised 2.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $215.5 Million, While China is Forecast to Grow at 0.9% CAGR

The Positron Emission Tomography (PET) market in the U.S. is estimated at US$215.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$140.6 Million by the year 2027 trailing a CAGR of 0.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 0.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Other Product Types Segment to Record 1.5% CAGR

In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 1.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$16.9 Million in the year 2020 will reach a projected size of US$18.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$88.9 Million by the year 2027.

Select Competitors (Total 42 Featured) -

  • GE Healthcare
  • Hitachi Ltd.
  • Neusoft Corporation
  • Philips Healthcare
  • Siemens Healthineers
  • Toshiba Corporation
  • United Imaging

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Positron Emission Tomography (PET) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Positron Emission Tomography (PET) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Positron Emission Tomography (PET) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for PET-CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for PET-CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for PET-CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for PET-MR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for PET-MR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for PET-MR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Positron Emission Tomography (PET) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Positron Emission Tomography (PET) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Positron Emission Tomography (PET) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 85: Rest of Europe Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 88: Asia-Pacific Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 91: Asia-Pacific Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 94: Rest of World Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of World Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42